Publicaciones en colaboración con investigadores/as de Instituto de Salud Global de Barcelona (20)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

2022

  1. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

2019

  1. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

    Nature Communications, Vol. 10, Núm. 1

  2. Combined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii

    Microorganisms, Vol. 7, Núm. 11

  3. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

    Nature Genetics, Vol. 51, Núm. 5, pp. 804-814

2018

  1. Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade

    Scientific Reports, Vol. 8, Núm. 1

  2. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 599-603

  3. Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii

    Frontiers in Microbiology, Vol. 9

2017

  1. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3277-3282

  2. Overproduction of Outer membrane protein a by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase

    Journal of Infectious Diseases, Vol. 215, Núm. 6, pp. 966-974

2016

  1. Genome-wide associations for birth weight and correlations with adult disease

    Nature, Vol. 538, Núm. 7624, pp. 248-252

  2. Genomic evolution of two Acinetobacter baumannii clinical strains from ST-2 clones isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)

    Genome Announcements, Vol. 4, Núm. 5

  3. Online SERS Quantification of Staphylococcus aureus and the Application to Diagnostics in Human Fluids

    Advanced Materials Technologies, Vol. 1, Núm. 8

  4. Ultrasensitive multiplex optical quantification of bacteria in large samples of biofluids

    Scientific Reports, Vol. 6

2015

  1. Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229

2014

  1. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633

  2. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126

  3. Nosocomial outbreak of a multiresistant acinetobacter baumannii expressing OXA-23 carbapenemase in Spain

    Microbial Drug Resistance, Vol. 20, Núm. 4, pp. 259-263